Welcome aboard Dr. In!!!!! Rutgers Cancer Institute RWJBarnabas #LetsBeatCancerTogether

Center of Excellence for Cancer Immunology and Metabolism Rutgers Cancer Institute is seeking exceptional cancer immunologists jobs.rutgers.edu/postings/120928 & tumor immunology researchers jobs.rutgers.edu/postings/120926 to join our National Cancer Institute-Designated Comprehensive Cancer Center!

We are pleased to announce Dr. Kevin David as the new director of the Lymphoma Program Rutgers Cancer Institute! Dr. David leads a multidisciplinary team of experts who provide exceptional expertise, knowledge & skill with advanced therapies to treat #lymphoma. RWJBarnabas Rutgers RWJMedSchool

Excited to share our work on the potential role of preventative immunotherapy in high risk oral leukoplakia 🧐👀🩺 Dana-Farber News Ravi Uppaluri, MDPhD Bristol Myers Squibb Sookbin Woo @HNOPDFCI AACR

Such an honor to work with the incredibly dedicated team at JITC, lead by Dr. Romero. ❤️Love our mission. Efficiently and effectively sharing meaningful new discoveries to impact the lives of patients with cancer.

.Rutgers Cancer Institute is seeking a nationally recognized research-focused pathologist to serve as the Chief of Cancer Pathology and Director of the Biorepository &Histopathology Service at Rutgers Cancer Institute. For more details please visit: jobs.rutgers.edu/postings/133814

#ASHKudos to Robert Wood Johnson University Hospital Rutgers Cancer Institute Heme/Onc fellow Dr Jiequi (Janice) Liu for leading the multicenter RWE project of CD19 #CART Therapy in Solid Organ Transplant (SOT)-Related #PTLD; it provides the largest analysis to date of CD19 CAR-T SOT-related PTLD. ash.confex.com/ash/2021/webpr…

From diagnosis, to treatment, to survivorship, the Rutgers Cancer Institute RWJBarnabas Jack & Sheryl Morris Cancer Center will serve as a beacon of hope & destination for those who need it most. The 12 story, 510,000 s.f. facility is set for completion in 2024! cinj.org/about-cinj/jac…

🙌 A big welcome to Ira Braunschweig, MD, as the new Chief of the Section of Transplant and Cell Therapy at Rutgers Cancer Institute & Chief of the Transplant and Cell Therapy Service at RWJBarnabas Oncology Service Line: cinj.org/new-chief-bone…. #CellTherapy #BMT #LetsBeatCancerTogether

What a great honor to celebrate with so many friends!

NCI Division of Cancer Biology 1/2 Cell Therapy, approved for heme malignancies, is now demonstrating activity in solid tumors. Our collaboration with Christian Hinrichs has demonstrated amazing response rates in #HPV associated cancers with TCR engineered T-cells. nature.com/articles/s4159… #CIM22 #CIMChat22

Work by John Davies finding in multiple solid tumor T cell therapy models that PD-1 blockade acts through endogenous rather than transferred T cells to mediate a non-synergistic anti-tumor effect. It will be interesting to see clinical data from the many active studies.

Thanks to Tracie Saunders RN, OHRS Exec Dir reporting on our new cellular therapy #clinicaltrials for solid tumors, working with Dr ⁦Christian Hinrichs⁩. Latest in TCR cell therapy now ⁦Rutgers Cancer Institute⁩ ⁦RWJBarnabas⁩

In this Perspective, we consolidate lessons from clinical experience and describe key issues going forward in the development of cell therapy for epithelial cancers. sciencedirect.com/science/articl…

NOW OPEN Rutgers Cancer Institute: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” Christian Hinrichs #ClinicalTrial #CancerResearch #HPV #hpvvaccine RWJBarnabas ow.ly/fuwc50O9f7e

NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas cinj.org/clinical-trial…

NOW OPEN Rutgers Cancer Institute: “A Phase II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers” Christian Hinrichs #ClinicalTrial #CancerResearch RWJBarnabas cinj.org/clinical-trial…

NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the #Stomach, #Breast, #Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas #BCSM cinj.org/clinical-trial…

A big thank you to Rutgers W.Basketball coach Coquese Washington Coquese Washington and Rutgers W.Basketball Chief of Staff Stephen Fishler Stephen Fishler for visiting us at Rutgers Cancer Institute today! 🏀 RWJBarnabas Rutgers Scarlet Knights Andrew M. Evens, DO, MBA, MSc Steven Libutti

NOW OPEN Rutgers Cancer Institute: “A Phase I Trial of T Cell Receptor Gene Therapy Targeting KK-LC-1 for Cancers of the Stomach, Breast, Lung and Cervix.” #ClinicalTrial #CancerResearch Christian Hinrichs RWJBarnabas cinj.org/clinical-trial…